Pro-Dex (PDEX) vs Treace Medical Concepts (TMCI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Pro-Dex (PDEX) has outperformed Treace Medical Concepts (TMCI) over the past year, gaining 91.3% versus a loss of 35.2%. Over five years, PDEX leads with a +144.3% price change compared with -84.1% for TMCI. Treace Medical Concepts is the larger company by market cap ($253.0 million vs $201.2 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PDEX | TMCI |
|---|---|---|
| Share price | $62.80 | $3.89 |
| Market cap | $201.17M | $252.98M |
| 1-day change | -3.27% | -2.75% |
| YTD return | +63.20% | +58.78% |
| 1-year return | +91.35% | -35.17% |
| 5-year return | +144.26% | -84.07% |
| P/E ratio (TTM) | 15.94 | — |
| Forward P/E | 18.69 | — |
| EPS (TTM) | $3.94 | $-0.92 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $77.00 | $7.08 |
| 52-week low | $23.47 | $1.17 |
| Distance from 52-week high | -18.44% | -45.06% |
| Analyst consensus | none | none |
| Avg. price target upside | +17.83% | +41.39% |
| Average volume | 81.50K | 333.87K |
| Shares outstanding | 3.20M | 65.03M |
| Employees | 201 | 450 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Instruments & Supplies | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PDEX has outperformed TMCI by 126.5 percentage points over the past year.
About Pro-Dex
PDEX stock →Pro-Dex, Inc. designs, develops, manufactures, and repairs powered surgical instruments for medical device original equipment manufacturers worldwide.
Healthcare · Medical Instruments & Supplies · 201 employees
About Treace Medical Concepts
TMCI stock →Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions.
Healthcare · Medical Devices · 450 employees
PDEX vs TMCI FAQ
Which is bigger, Pro-Dex or Treace Medical Concepts?
Treace Medical Concepts (TMCI) is larger, with a market capitalization of $252.98M compared with $201.17M for Pro-Dex (PDEX).
Which stock has performed better over the past year, PDEX or TMCI?
PDEX returned +91.35% over the past 12 months, compared with -35.17% for TMCI (price return, excluding dividends). Past performance does not predict future results.
Are Pro-Dex and Treace Medical Concepts in the same industry?
Both are in the Healthcare sector, but in different industries: Medical Instruments & Supplies for Pro-Dex and Medical Devices for Treace Medical Concepts.